Literature DB >> 8481223

Multicenter study of predictors of disease course in Alzheimer disease (the "predictors study"). II. Neurological, psychiatric, and demographic influences on baseline measures of disease severity.

M Richards1, M Folstein, M Albert, L Miller, F Bylsma, G Lafleche, K Marder, K Bell, M Sano, D Devanand.   

Abstract

The "Predictors Study" is a prospective cohort study of the natural history of Alzheimer disease (AD), the aim of which is to identify milestones in disease progression and to develop a model to predict disease course in individual patients. The empirical background to this study is based on previous reports that the presence of extrapyramidal signs (EPS), myoclonus, and psychosis in AD may signify greater disease severity at any given stage and a more rapid course of the disease over time. The present analyses were conducted to determine whether these independent "predictor" variables were associated with greater disease severity at baseline within a new cohort of 224 mild AD patients recruited from three different medical centers (in New York, Baltimore, and Boston). Measures of disease severity were provided by the modified Mini-Mental State Examination (mMMSE) and the Blessed Dementia Rating Scale (BDRS), which measures functional capacity. Independent variables were EPS, delusions, and slowing of the posterior dominant EEG rhythm. The frequency of myoclonus and hallucinations was too low to permit adequate statistical assessment of their effects at this time. EPS and EEG slowing were associated with low mMMSE scores, whereas delusions were primarily associated with impaired functional capacity. These effects were independent of the influence of age and disease duration. These results indicate that the effects of these independent variables can be detected at mild stages of AD and that these effects can be generalized across different geographical regions.

Entities:  

Mesh:

Year:  1993        PMID: 8481223     DOI: 10.1097/00002093-199307010-00003

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  18 in total

1.  Utilization of antihypertensives, antidepressants, antipsychotics, and hormones in Alzheimer disease.

Authors:  Carolyn W Zhu; Elayne E Livote; Kristin Kahle-Wrobleski; Nikolaos Scarmeas; Marilyn Albert; Jason Brandt; Deborah Blacker; Mary Sano; Yaakov Stern
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Apr-Jun       Impact factor: 2.703

2.  Social cognition in Alzheimer's disease: a separate construct contributing to dependence.

Authors:  Stephanie Cosentino; Laura B Zahodne; Jason Brandt; Deborah Blacker; Marilyn Albert; Bruno Dubois; Yaakov Stern
Journal:  Alzheimers Dement       Date:  2014-03-18       Impact factor: 21.566

3.  Reduced Awareness of Memory Deficit is Associated With Increased Medicare Home Health Care Use in Dementia.

Authors:  Brittany DeFeis; Silvia Chapman; Carolyn Zhu; Martina Azar; Preeti Sunderaraman; Katherine Ornstein; Yian Gu; Stephanie Cosentino
Journal:  Alzheimer Dis Assoc Disord       Date:  2019 Jan-Mar       Impact factor: 2.703

4.  Longitudinal medication usage in Alzheimer disease patients.

Authors:  Carolyn W Zhu; Elayne E Livote; Kristin Kahle-Wrobleski; Nikolaos Scarmeas; Marilyn Albert; Jason Brandt; Deborah Blacker; Mary Sano; Yaakov Stern
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Oct-Dec       Impact factor: 2.703

5.  Health-care use and cost in dementia caregivers: Longitudinal results from the Predictors Caregiver Study.

Authors:  Carolyn W Zhu; Nikolaos Scarmeas; Katherine Ornstein; Marilyn Albert; Jason Brandt; Deborah Blacker; Mary Sano; Yaakov Stern
Journal:  Alzheimers Dement       Date:  2014-03-15       Impact factor: 21.566

6.  Clinical characteristics and longitudinal changes of informal cost of Alzheimer's disease in the community.

Authors:  Carolyn W Zhu; Nikolaos Scarmeas; Rebecca Torgan; Marilyn Albert; Jason Brandt; Deborah Blacker; Mary Sano; Yaakov Stern
Journal:  J Am Geriatr Soc       Date:  2006-10       Impact factor: 5.562

7.  The effects of patient function and dependence on costs of care in Alzheimer's disease.

Authors:  Carolyn W Zhu; Christopher Leibman; Trent McLaughlin; Nikolaos Scarmeas; Marilyn Albert; Jason Brandt; Deborah Blacker; Mary Sano; Yaakov Stern
Journal:  J Am Geriatr Soc       Date:  2008-07-24       Impact factor: 5.562

8.  Long-term associations between cholinesterase inhibitors and memantine use and health outcomes among patients with Alzheimer's disease.

Authors:  Carolyn W Zhu; Elayne E Livote; Nikolaos Scarmeas; Marilyn Albert; Jason Brandt; Deborah Blacker; Mary Sano; Yaakov Stern
Journal:  Alzheimers Dement       Date:  2013-01-17       Impact factor: 21.566

9.  Distinct pools of beta-amyloid in Alzheimer disease-affected brain: a clinicopathologic study.

Authors:  Joshua R Steinerman; Michael Irizarry; Nikolaos Scarmeas; Susan Raju; Jason Brandt; Marilyn Albert; Deborah Blacker; Bradley Hyman; Yaakov Stern
Journal:  Arch Neurol       Date:  2008-07

10.  Longitudinal relationships between Alzheimer disease progression and psychosis, depressed mood, and agitation/aggression.

Authors:  Laura B Zahodne; Katherine Ornstein; Stephanie Cosentino; D P Devanand; Yaakov Stern
Journal:  Am J Geriatr Psychiatry       Date:  2013-07-17       Impact factor: 4.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.